Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Finished Goods: 2022

  • Amylyx Pharmaceuticals' Finished Goods was N/A to $937,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $937,000, marking a year-over-year change of. This contributed to the annual value of $937,000 for FY2022, which is N/A change from last year.
  • According to the latest figures from Q4 2022, Amylyx Pharmaceuticals' Finished Goods is $937,000, which was up 751.82% from $110,000 recorded in Q3 2022.
  • Over the past 5 years, Amylyx Pharmaceuticals' Finished Goods peaked at $937,000 during Q4 2022, and registered a low of $110,000 during Q3 2022.
  • In the last 1 years, Amylyx Pharmaceuticals' Finished Goods had a median value of $523,500 in 2022 and averaged $523,500.